Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
15.64B | 17.52B | 20.03B | 18.34B | 14.46B | Gross Profit |
9.09B | 11.02B | 13.77B | 12.38B | 9.27B | EBIT |
5.46B | 7.33B | 10.14B | 8.96B | 5.89B | EBITDA |
7.54B | 9.01B | 11.22B | 10.06B | 7.20B | Net Income Common Stockholders |
4.80B | 6.51B | 8.75B | 7.77B | 5.59B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.58B | 8.57B | 9.07B | 9.74B | 6.57B | Total Assets |
35.51B | 32.35B | 27.21B | 24.68B | 19.35B | Total Debt |
13.60B | 11.22B | 8.73B | 7.74B | 6.80B | Net Debt |
10.40B | 8.26B | 5.68B | 3.11B | 3.69B | Total Liabilities |
18.61B | 15.45B | 12.63B | 11.34B | 10.16B | Stockholders Equity |
16.90B | 16.90B | 14.58B | 13.33B | 9.19B |
Cash Flow | Free Cash Flow | |||
1.50B | 1.35B | 5.92B | 6.29B | 5.49B | Operating Cash Flow |
6.32B | 6.42B | 8.72B | 8.76B | 6.14B | Investing Cash Flow |
-3.20B | -4.36B | -3.58B | -4.09B | -922.00M | Financing Cash Flow |
-2.88B | -2.14B | -6.72B | -3.14B | -4.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $103.14B | 16.61 | 35.19% | 1.26% | 4.45% | -10.01% | |
76 Outperform | $140.97B | 13.62 | 41.96% | 2.67% | 12.13% | 36.17% | |
75 Outperform | $72.33B | 15.56 | 10.10% | 0.71% | 71.05% | ― | |
72 Outperform | $138.97B | 85.49 | 2.89% | ― | 13.69% | 91.75% | |
71 Outperform | $81.64B | 52.49 | 4.43% | 2.28% | -19.28% | -44.00% | |
65 Neutral | $137.75B | 29.14 | 28.25% | 3.51% | -10.72% | -26.60% | |
57 Neutral | $18.54B | 9.84 | -14.38% | 2.71% | 5.07% | -23.65% |